Publications by authors named "Ornella Conort"

Claim this Profile
I
Impact of a clinical pharmacist consultation on enhancing knowledge and safety skills in patients with chronic inflammatory arthritis treated with bDMARDs.
Cécile Bottois, Clementina Lopez Medina, Sophie Dumas, Julien Hubert, Sephora Belo, Ornella Conort

Clin Exp Rheumatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Evaluation of medication self-administration feasibility in a university hospital: Clinical audits and recommendations].
Cyril Baudrier, Victoire Petitcuenot, Nacima Oussedik, William Champeau, Rouba Alarab, Ornella Conort

Ann Pharm Fr· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Translation and adaptation of a tool prescribing errors related to computerized physician order entry coding to the French hospital background].
Manon Videau, Bruno Charpiat, Ornella Conort, Audrey Janoly-Dumenil, Pierrick Bedouch

Ann Pharm Fr· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the French version of the Compliance Questionnaire for Rheumatology (CQR-5), a self-reporting questionnaire specific to patients with chronic inflammatory rheumatic disease.
Pauline Cavagna, Julien Hubert, Cécile Bottois, Clementina Lopez-Medina, Christian Roux, Ornella Conort

Joint Bone Spine· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of a clinical pharmacist in a multidisciplinary consultation on the switch to a biosimilar for inflammatory rheumatic diseases.
Clara Levivien, Cécile Bottois, Clementina López Medina, Sophie Dumas, Julien Hubert, Ornella Conort

Joint Bone Spine· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of Rituximab biosimilar GP2013 in chronic inflammatory rheumatic disorders in daily clinical practice.
Jérôme Avouac, Rodolphe Cougnaud Murail, Claire Goulvestre, Sophie Dumas, Anna Molto, Ornella Conort

Semin Arthritis Rheum· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of pharmacist's interventions triggered by prescribing errors related to computerised physician order entry in French hospitals: a cross-sectional observational study.
Manon Videau, Bruno Charpiat, Céline Vermorel, Jean-Luc Bosson, Ornella Conort

BMJ Open· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of a pharmacist-led programme on biologics knowledge and adherence in patients with spondyloarthritis.
Loriane Gutermann, Sophie Dumas, Clementina Lopez-Medina, Léa Boissinot, Camille Cotteret, Ornella Conort

Clin Exp Rheumatol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CLEO: a multidimensional tool to assess clinical, economic and organisational impacts of pharmacists' interventions.
Ha Thi Vo, Bruno Charpiat, Sebastien Chanoine, Michel Juste, Renaud Roubille, Ornella Conort

Eur J Hosp Pharm· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of successive switches to different biosimilars infliximab on immunogenicity in chronic inflammatory diseases in daily clinical practice.
Ambre Lauret, Anna Moltó, Vered Abitbol, Loriane Gutermann, Ornella Conort

Semin Arthritis Rheum· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic switch from innovator infliximab to biosimilar infliximab in inflammatory chronic diseases in daily clinical practice: The experience of Cochin University Hospital, Paris, France.
Jérôme Avouac, Anna Moltó, Vered Abitbol, Adrien Etcheto, Axelle Salcion, Ornella Conort

Semin Arthritis Rheum· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tools for Assessing Potential Significance of Pharmacist Interventions: A Systematic Review.
Thi-Ha Vo, Bruno Charpiat, Claire Catoire, Michel Juste, Renaud Roubille, Ornella Conort

Drug Saf· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of clinical pharmacists' interventions in French hospitals: results of a multicenter study.
Pierrick Bedouch, Bruno Charpiat, Ornella Conort, François-Xavier Rose, Laurence Escofier

Ann Pharmacother· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Factors to consider in managing drug interactions in clinical practice].
Bruno Charpiat, Benoit Allenet, Renaud Roubille, Laurence Escofier, Pierrick Bedouch, Ornella Conort

Presse Med· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Pharmacists' interventions before and after prescription computerization in an internal medicine department].
Frédérique Bouchand, Audrey Thomas, Lilia Zerhouni, Alain Dauphin, Ornella Conort

Presse Med· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of an instrument for the documentation of clinical pharmacists' interventions.
Benoît Allenet, Pierrick Bedouch, François-Xavier Rose, Laurence Escofier, Renaud Roubille, Ornella Conort

Pharm World Sci· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous to oral conversion of fluoroquinolones: knowledge versus clinical practice patterns.
Ornella Conort, Steven Gabardi, Marie-Pauline Didier, Georges Hazebroucq, Alain Cariou

Pharm World Sci· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis